SCHEMBL9506851

SCHEMBL9506851

CC(=O)Oc1ccc(C(C)c2ccc(OC(C)=O)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.59
MAPT P10636 3/20 0.53
POLB P06746 1/20 0.53
PKM P14618 1/20 0.53
ELANE P08246 4/20 0.52
ESR1 P03372 4/20 0.51
KDM4E B2RXH2 3/20 0.51
CYP3A4 P08684 3/20 0.51
SLC6A3 Q01959 2/20 0.51
HIF1A Q16665 2/20 0.51
ABCB11 O95342 1/20 0.51
ADRA2A P08913 1/20 0.51
CYP2C9 P11712 1/20 0.51
TSHR P16473 1/20 0.51
PDE4A P27815 1/20 0.51
ADRA1A P35348 1/20 0.51
OPRK1 P41145 1/20 0.51
STAT6 P42226 1/20 0.51
GPR55 Q9Y2T6 1/20 0.51
HSD17B10 Q99714 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14242097 0.92 ESR1 (0.59) LMNAMAPTPOLBPKMELANE
SCHEMBL28927408 0.92 ELANE (0.59) LMNAMAPTPOLBPKMELANE
SCHEMBL13595800 0.92 ESR1 (0.59) LMNAMAPTPOLBPKMELANE
SCHEMBL12021697 0.92 LMNA (0.52) LMNAMAPTPOLBPKMELANE
SCHEMBL2691203 0.91 ELANE (0.53) LMNAMAPTPOLBPKMELANE
SCHEMBL13133162 0.88 ESR1 (0.63) LMNAMAPTPOLBPKMELANE
Phenol SCHEMBL10624777 0.88 ELANE (0.54) LMNAMAPTPOLBPKMELANE
SCHEMBL1714626 0.87 LMNA (0.59) LMNAMAPTPOLBPKMELANE
SCHEMBL715235 0.86 LMNA (0.53) LMNAMAPTPOLBPKMELANE
Hydrogen Peroxide SCHEMBL9578945 0.85 LMNA (0.57) LMNAMAPTPOLBPKMELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4892912-A DEPOLYMERIZATION THEN POLYMERIZING FRAGMENTS, ELASTICITY, MECHANICAL STRENGTH IDEMITSU PETROCHEMICAL CO., LTD. (JP) 1990-01-09 US claimed
US-20140186872-A1 BISACODYL AND ITS ANALOGUES AS DRUGS FOR USE IN THE TREATMENT OF CANCER CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE- CNRS (FR) 2014-07-03 US disclosed
US-20140186872-A1 BISACODYL AND ITS ANALOGUES AS DRUGS FOR USE IN THE TREATMENT OF CANCER CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE- CNRS (FR) 2014-07-03 US disclosed
WO-2012168885-A2 BISACODYL AND ANALOGUES AS DRUGS FOR TREATING CANCER UNIVERSITÉ DE STRASBOURG (FR) 2012-12-13 WO disclosed
EP-0321691-B1 PROCESS FOR PRODUCING AROMATIC POLYESTER IDEMITSU PETROCHEMICAL CO. LTD. (JP) 1993-09-29 EP disclosed
US-4892912-A DEPOLYMERIZATION THEN POLYMERIZING FRAGMENTS, ELASTICITY, MECHANICAL STRENGTH IDEMITSU PETROCHEMICAL CO., LTD. (JP) 1990-01-09 US disclosed
EP-0321691-A2 Process for producing aromatic polyester IDEMITSU PETROCHEMICAL CO. LTD. (JP) 1989-06-28 EP disclosed
EP-0212482-B1 PROCESS FOR OBTAINING NEGATIVE IMAGES FROM POSITIVE PHOTORESISTS HOECHST CELANESE CORPORATION (US) 1989-04-19 EP disclosed
EP-0106156-B1 LIGHT-SENSITIVE COMPOSITION HOECHST CELANESE CORPORATION (US) 1988-12-21 EP disclosed
EP-0212482-A2 Process for obtaining negative images from positive photoresists HOECHST CELANESE CORPORATION (US) 1987-03-04 EP disclosed
EP-0061150-B1 LIGHT-SENSITIVE POLYCONDENSATION PRODUCT, PROCESS FOR ITS PREPARATION AND LIGHT-SENSITIVE RECORDING MATERIAL CONTAINING THE SAME AMERICAN HOECHST CORPORATION (US) 1986-10-15 EP disclosed
EP-0106156-A2 Light-sensitive composition HOECHST CELANESE CORPORATION (US) 1984-04-25 EP disclosed
US-4436804-A Light-sensitive polymeric diazonium condensates and reproduction compositions and materials therewith AMERICAN HOECHST CORPORATION (US) 1984-03-13 US disclosed
US-4435496-A WITH FREE RADICAL PHOTOSENSITIZER AMERICAN HOECHST CORPORATION (US) 1984-03-06 US disclosed
EP-0061150-A1 Light-sensitive polycondensation product, process for its preparation and light-sensitive recording material containing the same AMERICAN HOECHST CORPORATION (US) 1982-09-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140186872-A1 BISACODYL AND ITS ANALOGUES AS DRUGS FOR USE IN THE TREATMENT OF CANCER CCND1, DEGS1, MCL1 LMNA 1234/4885MAPT 3710/4885POLB 1088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.